• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发甲型肝炎疫苗的可能方法。

Possible approaches to develop vaccines against hepatitis A.

作者信息

D'Hondt E

机构信息

SmithKline Beecham Biologicals, Rixensart, Belgium.

出版信息

Vaccine. 1992;10 Suppl 1:S48-52. doi: 10.1016/0264-410x(92)90542-r.

DOI:10.1016/0264-410x(92)90542-r
PMID:1335659
Abstract

More than a decade ago, successful replication of hepatitis A virus (HAV) in cell culture opened the way to the development of live attenuated and inactivated vaccine candidates. Serial passages of HAV in cell culture led to attenuation as demonstrated by experiments in non-human primates. Several live vaccine candidates obtained through serial passages have been evaluated in volunteers. Significant improvements in the yield of viral antigen from infected cell cultures stimulated the development of killed vaccine candidates. These formalin-inactivated vaccines contain the viral capsid antigens assembled into viral particles. The immunogenic potential of the vaccine candidates depends strongly on the preservation of the configuration of the capsid proteins. Synthetic peptides covering immunogenic sequences of VP1 as well as soluble capsid proteins expressed as fusion proteins in Escherichia coli were therefore only weakly immunogenic when injected at high concentrations in rabbits. On the other hand, tamarin monkeys immunized with a live recombinant vaccinia expressing P1 were protected against virulent challenge. There are, however, considerable drawbacks related to the use of live vaccinia as a carrier virus. Chimeric polio-HAV VP1 viruses have been constructed. These hybrid viruses were not able to induce an immune response, probably because of configurational constraints of poliovirus on the inserted HAV epitopes. More recently, encouraging data on empty virus particles expressed in baculovirus and vaccinia virus systems have been reported.

摘要

十多年前,甲型肝炎病毒(HAV)在细胞培养中的成功复制为减毒活疫苗和灭活疫苗候选物的开发开辟了道路。HAV在细胞培养中的连续传代导致其减毒,这在非人类灵长类动物实验中得到了证明。通过连续传代获得的几种活疫苗候选物已在志愿者中进行了评估。感染细胞培养物中病毒抗原产量的显著提高刺激了灭活疫苗候选物的开发。这些福尔马林灭活疫苗含有组装成病毒颗粒的病毒衣壳抗原。疫苗候选物的免疫原性潜力在很大程度上取决于衣壳蛋白构型的保留。因此,覆盖VP1免疫原性序列的合成肽以及在大肠杆菌中作为融合蛋白表达的可溶性衣壳蛋白,在以高浓度注射到兔子体内时,免疫原性很弱。另一方面,用表达P1的重组痘苗病毒活疫苗免疫的绢毛猴对强毒攻击具有抵抗力。然而,使用活痘苗作为载体病毒存在相当多的缺点。已经构建了嵌合脊髓灰质炎-HAV VP1病毒。这些杂种病毒无法诱导免疫反应,可能是由于脊髓灰质炎病毒对插入的HAV表位的构型限制。最近,有报道称在杆状病毒和痘苗病毒系统中表达的空病毒颗粒有令人鼓舞的数据。

相似文献

1
Possible approaches to develop vaccines against hepatitis A.开发甲型肝炎疫苗的可能方法。
Vaccine. 1992;10 Suppl 1:S48-52. doi: 10.1016/0264-410x(92)90542-r.
2
A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.
J Gen Virol. 1991 Sep;72 ( Pt 9):2167-72. doi: 10.1099/0022-1317-72-9-2167.
3
An inactivated hepatitis A viral vaccine of cell culture origin.一种细胞培养源的甲型肝炎灭活病毒疫苗。
J Med Virol. 1986 May;19(1):23-31. doi: 10.1002/jmv.1890190105.
4
Prevention of viral hepatitis A: past, present and future.甲型病毒性肝炎的预防:过去、现在与未来
Vaccine. 1992;10 Suppl 1:S10-4. doi: 10.1016/0264-410x(92)90532-o.
5
Further evaluation of a live hepatitis A vaccine in marmosets.狨猴中甲型肝炎活疫苗的进一步评估。
J Med Virol. 1991 Aug;34(4):227-31. doi: 10.1002/jmv.1890340406.
6
Antibody response to nonstructural proteins of hepatitis A virus following infection.甲型肝炎病毒感染后针对非结构蛋白的抗体反应。
J Med Virol. 1993 May;40(1):76-82. doi: 10.1002/jmv.1890400115.
7
Antigenic and immunogenic properties of a hepatitis A virus capsid protein expressed in Escherichia coli.在大肠杆菌中表达的甲型肝炎病毒衣壳蛋白的抗原性和免疫原性特性。
J Infect Dis. 1988 Jun;157(6):1203-11. doi: 10.1093/infdis/157.6.1203.
8
Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine.甲型肝炎疫苗的研发途径:一种灭活疫苗的开发与生产
J Infect Dis. 1995 Mar;171 Suppl 1:S33-9. doi: 10.1093/infdis/171.supplement_1.s33.
9
Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
Vaccine. 1992;10 Suppl 1:S106-9. doi: 10.1016/0264-410x(92)90559-3.
10
[The immunogenicity of a cultured inactivated hepatitis A vaccine].[一种培养的甲型肝炎灭活疫苗的免疫原性]
Vopr Virusol. 1991 May-Jun;36(3):206-9.

引用本文的文献

1
Nonhuman Primate Models of Hepatitis A Virus and Hepatitis E Virus Infections.甲型肝炎病毒和戊型肝炎病毒感染的非人灵长类动物模型。
Cold Spring Harb Perspect Med. 2019 Feb 1;9(2):a031815. doi: 10.1101/cshperspect.a031815.
2
Active immunization in the United States: developments over the past decade.美国的主动免疫:过去十年的发展情况
Clin Microbiol Rev. 2001 Oct;14(4):872-908, table of contents. doi: 10.1128/CMR.14.4.872-908.2001.